Oppenheimer maintained its Outperform rating on Trevi Therapeutics, Inc. (NASDAQ:TRVI) shares and lifted the price target ...

Oppenheimer increased its price target for Trevi Therapeutics Inc. (NASDAQ:TRVI) to $23 from $20, while maintaining an ...

“I hope it stays that way,” said Ernst, who worked in a medical research laboratory for a dozen years ... “It’s not always the beaker,” Uplinger said. Students were warming oil in ...

Once submitted, we will try and place you in contact with a suitable Liquid-Liquid Extraction (LLE) supplier within 48 hours.